Gamida Cell Ltd. - ROE
GMDA
Price:
$0.0327
Market Cap:
$4.34M
Gamida Cell Ltd. operates as a clinical-stage biopharmaceutical firm, dedicated to pioneering cell therapies aimed at eradicating blood cancers and other severe hematological conditions. The company's leading investigational product, omidubicel—a specialized cell therapy—has successfully concluded its Phase III clinical evaluation for individuals afflicted with high-risk hematologic malignancies. Furthermore, it is currently undergoing Phase I/II trials for patients suffering from severe aplastic anemia. Another significant therapeutic candidate, GDA-201, an immunotherapy harnessing natural killer cells, is progressing through Phase I/II studies to address relapsed or refractory non-Hodgkin ...[Read more]
Industry
Biotechnology
IPO Date
2018-10-26
Stock Exchange
NASDAQ
Ticker
GMDA
PE Ratio
[-0.04]
ROE
[1.15%]
Current Ratio
[2.16]
Dividend Yield
[0%]
Enterprise Value
[40.73M]
Dividend History
The ROE as of June 2026 (TTM) for Gamida Cell Ltd. (GMDA) is 1.15%
According to Gamida Cell Ltd.’s latest financial reports and current stock price. The company's current ROE is 1.15%. This represents a change of -5760.22% compared to the average of -20.29% of the last 4 quarters.
Gamida Cell Ltd. (GMDA) Historical ROE (quarterly & annually)
How has GMDA ROE performed in the past?
The mean historical ROE of Gamida Cell Ltd. over the last ten years is 396.28%. The current 1.15% ROE has changed 189.77% with respect to the historical average. Over the past ten years (40 quarters), GMDA's ROE was at its highest in in the December 2022 quarter at 540.43%. The ROE was at its lowest in in the June 2022 quarter at -466.24%.
Average
396.28%
Median
-90.50%
Minimum
-214.41%
Maximum
2.14%
Gamida Cell Ltd. (GMDA) ROE by Quarter and Year
Discovering the peaks and valleys of Gamida Cell Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 171.67%
Maximum Annual ROE = 2.14%
Minimum Annual Increase = -1014.72%
Minimum Annual ROE = -214.41%
| Year | ROE | Change |
|---|---|---|
| 2023 | 2.14% | 11.02% |
| 2022 | 1.92% | -1014.72% |
| 2021 | -210.34% | 171.67% |
| 2020 | -77.43% | -21.15% |
| 2019 | -98.19% | -54.20% |
| 2018 | -214.41% | 158.90% |
| 2017 | -82.81% | -59.95% |
Gamida Cell Ltd. (GMDA) Average ROE
How has GMDA ROE performed in the past?
The current ROE of Gamida Cell Ltd. (GMDA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.28%
5-year avg
734.86%
10-year avg
396.28%
Gamida Cell Ltd. (GMDA) ROE vs. Peers
How is GMDA’s ROE compared to its peers?
Gamida Cell Ltd.’s ROE is greater than Aptose Biosciences Inc. (-23.18%), greater than Gritstone bio, Inc. (-124.41%), greater than Nabriva Therapeutics plc (-201.91%), greater than TNF Pharmaceuticals, Inc. (-59.95%), greater than Atreca, Inc. (-83.28%), greater than Neuphoria Therapeutics Inc. (-109.66%), greater than Hillstream BioPharma, Inc. (-36.93%), greater than Altamira Therapeutics Ltd. (-111.64%), greater than Idera Pharmaceuticals, Inc. (-113.18%), greater than RVL Pharmaceuticals plc (-80.88%),
| Company | ROE | Market cap |
|---|---|---|
| -23.18% | $4.36M | |
| -124.41% | $3.80M | |
| -201.91% | $323.00 | |
| -59.95% | $9.18M | |
| -83.28% | $3.57M | |
| -109.66% | $23.29M | |
| -36.93% | $4.17M | |
| -111.64% | $1.13M | |
| -113.18% | $0 | |
| -80.88% | $3.14M |
Build a custom stock screener for Gamida Cell Ltd. (GMDA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gamida Cell Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Gamida Cell Ltd. (GMDA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Gamida Cell Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Gamida Cell Ltd.'s ROE?
How is the ROE calculated for Gamida Cell Ltd. (GMDA)?
What is the highest ROE for Gamida Cell Ltd. (GMDA)?
What is the 3-year average ROE for Gamida Cell Ltd. (GMDA)?
What is the 5-year average ROE for Gamida Cell Ltd. (GMDA)?
How does the current ROE for Gamida Cell Ltd. (GMDA) compare to its historical average?